(2026). Stemness and EMT profiles shift in xenografts derived from cisplatin-sensitive and cisplatin-tolerant ovarian cancer cells. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Stemness and EMT Profiles Shift in Xenografts Derived from Cisplatin-sensitive and Cisplatin-tolerant Ovarian Cancer Cells."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Stemness and EMT Profiles Shift in Xenografts Derived from Cisplatin-sensitive and Cisplatin-tolerant Ovarian Cancer Cells."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.